Two major pharmaceutical companies — GlaxoSmithKline and Pfizer — recently changed their continuing medical education granting process to eliminate medical education and communication companies as prospective recipients of unrestricted grants. To many CME providers, this seems like a vote of no confidence in MECCs' ability to provide high-quality, independent, unbiased, and effective CME, compared to societies, academic centers, and others who provide accredited CME. What ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.